AI assistant
Indoco Remedies Ltd. — Regulatory Filings 2025
Dec 29, 2025
62453_rns_2025-12-29_4c7a4951-ed76-4ba6-aaa0-705be70bf7b1.pdf
Regulatory Filings
Open in viewerOpens in your device viewer
==> picture [199 x 70] intentionally omitted <==
29[th] December, 2025
| To The Listing Department National Stock Exchange of India Limited Exchange Plaza, Bandra – Kurla Complex Bandra (East) Mumbai – 400 051 Stock Code : INDOCO |
To The Listing Department Bombay Stock Exchange Limited Floor 25, P. J. Towers, Dalal Street, Mumbai – 400 001 _Stock Code :_532612 |
|
|---|---|---|
Dear Sir/Madam,
Subject: Intimation of Analyst/ Institutional Investors Meet under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Pursuant to Regulation 30(6) read with Para A of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the senior management of the Company shall be meeting analysts/investors as follows:-
| Date | Particulars- Investor Conference |
Type of Meeting |
Mode of Interaction |
|---|---|---|---|
| 18thFebruary, 2026 | Dolat Capital Corporate Conference 2026 - “Decoding Growth Strategies” |
Group meeting |
Physical Meeting at Grand Hyatt, Santacruz, Mumbai |
Please note that the details are subject to change. Changes may happen due to exigencies on the part of investors or the Company. No unpublished price sensitive information pertaining to the Company is shared at any of the meets with Analysts/Institutional Investors.
You are requested to kindly take note of the same.
Thanking you, Yours faithfully, For Indoco Remedies Limited
Digitally signed by RAMANATHA RAMANATHAN HARIHARAN N HARIHARAN Date: 2025.12.29 22:18:24 +05'30'
Ramanathan Hariharan Company Secretary & Head Legal
==> picture [593 x 75] intentionally omitted <==